![Joyce Heinzerling Davis](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Joyce Heinzerling Davis
Director/Board Member at KOP Therapeutics Corp.
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Tibor Gajdics | M | 65 |
KOP Therapeutics Corp.
![]() KOP Therapeutics Corp. BiotechnologyHealth Technology KOP Therapeutics Corp. operates as a biotechnology company which focuses on the validation and commercialization of its newly discovered genomic drug platform. The company was founded in 2018 and is headquartered in Vancouver, Canada. | 6 years |
Ian Hollis Mann | M | 66 |
KOP Therapeutics Corp.
![]() KOP Therapeutics Corp. BiotechnologyHealth Technology KOP Therapeutics Corp. operates as a biotechnology company which focuses on the validation and commercialization of its newly discovered genomic drug platform. The company was founded in 2018 and is headquartered in Vancouver, Canada. | 5 years |
Mark Redcliffe | M | - |
KOP Therapeutics Corp.
![]() KOP Therapeutics Corp. BiotechnologyHealth Technology KOP Therapeutics Corp. operates as a biotechnology company which focuses on the validation and commercialization of its newly discovered genomic drug platform. The company was founded in 2018 and is headquartered in Vancouver, Canada. | - |
Marco Strub | M | 68 |
KOP Therapeutics Corp.
![]() KOP Therapeutics Corp. BiotechnologyHealth Technology KOP Therapeutics Corp. operates as a biotechnology company which focuses on the validation and commercialization of its newly discovered genomic drug platform. The company was founded in 2018 and is headquartered in Vancouver, Canada. | - |
Jakson Inwentash | M | 30 |
KOP Therapeutics Corp.
![]() KOP Therapeutics Corp. BiotechnologyHealth Technology KOP Therapeutics Corp. operates as a biotechnology company which focuses on the validation and commercialization of its newly discovered genomic drug platform. The company was founded in 2018 and is headquartered in Vancouver, Canada. | 2 years |
Aziz-Ur Rehman | M | 51 |
KOP Therapeutics Corp.
![]() KOP Therapeutics Corp. BiotechnologyHealth Technology KOP Therapeutics Corp. operates as a biotechnology company which focuses on the validation and commercialization of its newly discovered genomic drug platform. The company was founded in 2018 and is headquartered in Vancouver, Canada. | 3 years |
Connections Chart
Multi-company connection
Statistics
Country | Connections | % of total |
---|---|---|
Canada | 6 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Joyce Heinzerling Davis
- Personal Network